WEIWANGWEI WANG12388WANG, WEIAssistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonHematopathologyLeukemiaMD AndersonJORGE ECORTESJORGE E CORTES8637CORTES, JORGE EProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorZHENYATANGZHENYA TANG9946TANG, ZHENYAAssistant ProfessorCARLOS EBUESO-RAMOSCARLOS E BUESO-RAMOS8487BUESO-RAMOS, CARLOS EProfessorL JEFFREYMEDEIROSL JEFFREY MEDEIROS8762MEDEIROS, L JEFFREYProfessorJOSEPHKHOURYJOSEPH KHOURY8966KHOURY, JOSEPHAssociate ProfessorELIAS JOSEPHJABBOURELIAS JOSEPH JABBOUR9124JABBOUR, ELIAS JOSEPHAssociate ProfessorGUILLERMOGARCIA-MANEROGUILLERMO GARCIA-MANERO8853GARCIA-MANERO, GUILLERMOProfessor25888368Wang W, Tang G, Cortes JE, Liu H, Ai D, Yin CC, Li S, Khoury JD, Bueso-Ramos C, Medeiros LJ, Hu SJournal of hematology & oncologyChromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis. J Hematol Oncol. 2015 Apr 08; 8:32.J Hematol Oncol2015-04-08T00:00:002015Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis.74Professor10Assistant Professor14Associate ProfessorKOICHITAKAHASHIKOICHI TAKAHASHI11823TAKAHASHI, KOICHIAssistant Professor1515 Holcombe BlvdHouston77030-4009TX0.8363240.020611430research areas1.311160.1342338coauthor of25.51282.1596760similar to1120selected publicationsAuthorship 841450Authorship 842040Authorship 845910Authorship 847205Authorship 848537Authorship 850410Authorship 853699Authorship 853800Authorship 856972Authorship 858057Authorship 859099Authorship 859459Authorship 860472Authorship 860496Authorship 863646Authorship 866117Leukemia and LymphomaDNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia. Leukemia and Lymphoma. 1-5.DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemiaBlood Cancer JournalClinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia. Blood Cancer Journal. 6.Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemiaMolecular CytogeneticsSex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms. Molecular Cytogenetics. 9.Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasmsOncotargetAlterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer. Oncotarget. 6:36894-36902.Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancerJournal of HematopathologySubcutaneous panniculitis-like T cell lymphoma with mesenteric involvement. Journal of Hematopathology. 6:155-159.Subcutaneous panniculitis-like T cell lymphoma with mesenteric involvementLeukemiaDifferential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Leukemia. Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapyBloodRisk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood. 127:2742-2750.Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapyJournal of Hematology and OncologyChromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia. Journal of Hematology and Oncology. 8.Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemiaBloodClinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors. Blood. 126:1699-1706.Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitorsBlood Cancer JournalDifferential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood Cancer Journal. 6.Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapyHuman PathologyDouble-hit follicular lymphoma with MYC and BCL2 translocations. Human Pathology. 58:72-77.Double-hit follicular lymphoma with MYC and BCL2 translocationsJNCCN Journal of the National Comprehensive Cancer NetworkCytogenetic evolution associated with disease progression in Hematopoietic neoplasms with t(8;22)(p11;q11)/BCR-FQFR1 rearrangement. JNCCN Journal of the National Comprehensive Cancer Network. 14:708-711.Cytogenetic evolution associated with disease progression in Hematopoietic neoplasms with t(8;22)(p11;q11)/BCR-FQFR1 rearrangementAnnals of HematologyRole of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. Annals of Hematology. 1-4.Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapyBloodComplete remission in a patient with JAK2- and IDH2-positive myelofibrosis. Blood. 128:877-880.Complete remission in a patient with JAK2- and IDH2-positive myelofibrosisInternational Journal of Laboratory HematologyT-lymphoid or T/myeloid blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. International Journal of Laboratory Hematology. T-lymphoid or T/myeloid blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapyAmerican Journal of HematologyRefractory hairy cell leukemia-variant. American Journal of Hematology. Refractory hairy cell leukemia-variantAuthorship 8871941D056726DisordersProcedures41610830.697933Genetic Association StudiesD015477Disorders914260.726134Leukemia, Myelomonocytic, ChronicD002883Anatomy1282720.869085Chromosomes, Human, Pair 14D002894Anatomy721080.952558Chromosomes, Human, Pair 4D014178Physiology35012450.648213Translocation, GeneticAuthorship 924841129908419Wang W, Routbort MJ, Loghavi S, Tang Z, Medeiros LJ, Wang SALeukemia researchCharacterization of chronic myelomonocytic leukemia with TP53 mutations. Leuk Res. 2018 07; 70:97-99.Leuk Res2018-05-31T00:00:002018Characterization of chronic myelomonocytic leukemia with TP53 mutations.Authorship 978528132099038Wang W, Beird H, Kroll CJ, Hu S, Bueso-Ramos CE, Fang H, Tang G, Tang Z, Wang F, Takahashi K, You MJ, Khoury JD, Medeiros LJ, Futreal PALeukemiaT(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid. Leukemia. 2020 09; 34(9):2509-2512.Leukemia2020-02-25T00:00:002020T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid.34058246Wang W, Zhang Q, Medeiros LJHuman pathologySyncytial variant of nodular sclerosis Hodgkin lymphoma: an under-emphasized variant. Hum Pathol. 2021 11; 117:115-125.Hum Pathol2021-05-28T00:00:002021Syncytial variant of nodular sclerosis Hodgkin lymphoma: an under-emphasized variant.Authorship 10234751true1ProfessorProfessortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professor